Text Size

Blood and Tissue Sample Collection for Future Colon Cancer Biomarker Studies in Patients Undergoing Colonoscopy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2008 by National Cancer Institute (NCI).
Recruitment status was  Recruiting
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00897403
First received: May 9, 2009
Last updated: August 11, 2009
Last verified: October 2008
History of Changes
  Purpose

RATIONALE: Collecting and storing samples of blood and tissue from patients undergoing colonoscopy to study in the laboratory may help doctors learn more about colon cancer and identify biomarkers related to colon cancer in the future.

PURPOSE: This laboratory study is collecting blood and tissue samples for future colon cancer biomarker studies in patients undergoing colonoscopy.


Condition Intervention
Colorectal Cancer
Health Status Unknown
 Other: biologic sample preservation procedure
Procedure: diagnostic colonoscopy

Study Type: Observational
Official Title: Discovery of Candidate Biomarkers in Colon Cancer and Precancers Repository

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Collection of blood and tissue [ Designated as safety issue: No ]

Estimated Enrollment: 3000
Study Start Date: February 2007
Detailed Description:

OBJECTIVES:

  • Collect blood and tissue samples (including polyps, abnormal growths, cancer, and normal tissue) from patients undergoing colonoscopy.

OUTLINE: Patients undergo blood and tissue sample collection during colonoscopy. Samples are stored for future biomarker proteomic profiling.

  Eligibility

Ages Eligible for Study:   25 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

DISEASE CHARACTERISTICS:

  • Scheduled for colonoscopy as routine screening or for a specific problem

PATIENT CHARACTERISTICS:

  • Not pregnant

PRIOR CONCURRENT THERAPY:

  • No concurrent participation in a clinical trial to treat cancer or prevent cancer recurrence
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00897403

Locations
United States, Tennessee
Dan Rudy Cancer Center at Saint Thomas Hospital Recruiting
Nashville, Tennessee, United States, 37205
Contact: Contact Person     615-222-2166        
Vanderbilt-Ingram Cancer Center - Cool Springs Recruiting
Nashville, Tennessee, United States, 37064
Contact: Daniel Liebler     615-936-7057        
Vanderbilt-Ingram Cancer Center at Franklin Recruiting
Nashville, Tennessee, United States, 37064
Contact: Daniel Liebler     615-936-7057        
Vanderbilt-Ingram Cancer Center Recruiting
Nashville, Tennessee, United States, 37232-6838
Contact: Clinical Trials Office - Vanderbilt-Ingram Cancer Center     800-811-8480        
Sponsors and Collaborators
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
Investigators
Study Chair: Daniel C. Liebler, PhD Vanderbilt-Ingram Cancer Center
  More Information

Additional Information:
Clinical trial summary from the National Cancer Institute's PDQ® database  This link exits the ClinicalTrials.gov site

No publications provided

ClinicalTrials.gov Identifier: NCT00897403     History of Changes
Other Study ID Numbers: CDR0000546530, VU-VICC-GI-0661, VU-VICC-IRB-061096
Study First Received: May 9, 2009
Last Updated: August 11, 2009
Health Authority: Unspecified

Keywords provided by National Cancer Institute (NCI):
colon cancer
health status unknown

Additional relevant MeSH terms:
Colonic Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
 Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases

ClinicalTrials.gov processed this record on May 16, 2013